Cargando…
Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients
AIM: The study was aimed to understand the underlying causes for the differences in propranolol pharmacokinetics (PK) between healthy and cirrhosis populations by using a systematic whole-body physiologically based pharmacokinetic (PBPK) model-building approach for suggesting model informed proprano...
Autores principales: | Kalam, Muhammad Nasir, Rasool, Muhammad Fawad, Alqahtani, Faleh, Imran, Imran, Rehman, Asim Ur, Ahmed, Naveed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982780/ https://www.ncbi.nlm.nih.gov/pubmed/33762817 http://dx.doi.org/10.2147/DDDT.S297981 |
Ejemplares similares
-
Physiologically
Based Pharmacokinetic
Model To Predict Metoprolol Disposition in Healthy and Disease Populations
por: Zamir, Ammara, et al.
Publicado: (2023) -
A Physiologically Based Pharmacokinetic Model for Predicting Diazepam Pharmacokinetics after Intravenous, Oral, Intranasal, and Rectal Applications
por: Khalid, Sundus, et al.
Publicado: (2021) -
A physiologically based pharmacokinetic model of cefepime to predict its pharmacokinetics in healthy, pediatric and disease populations
por: Talha Zahid, Muhammad, et al.
Publicado: (2023) -
Development and Evaluation of Physiologically Based Pharmacokinetic Drug–Disease Models for Predicting Rifampicin Exposure in Tuberculosis and Cirrhosis Populations
por: Rasool, Muhammad F., et al.
Publicado: (2019) -
Application of a physiologically based pharmacokinetic model in predicting captopril disposition in children with chronic kidney disease
por: Khalid, Sundus, et al.
Publicado: (2023)